Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	NAD+-protein-serine ADP-ribosyltransferase activity	PARP2 PARP1	4.67e-05	2	137	2	GO:0140805
GeneOntologyMolecularFunction	sulfonylurea receptor activity	ABCC9 ABCC8	4.67e-05	2	137	2	GO:0008281
GeneOntologyMolecularFunction	NAD DNA ADP-ribosyltransferase activity	PARP2 PARP1	1.40e-04	3	137	2	GO:0140294
GeneOntologyMolecularFunction	NAD+-protein-glutamate ADP-ribosyltransferase activity	PARP2 PARP1	2.78e-04	4	137	2	GO:0140807
GeneOntologyMolecularFunction	ABC-type transporter activity	ABCC9 ABCA8 ABCC8 ABCG2	3.54e-04	49	137	4	GO:0140359
GeneOntologyMolecularFunction	NAD+-protein-aspartate ADP-ribosyltransferase activity	PARP2 PARP1	4.61e-04	5	137	2	GO:0140806
GeneOntologyMolecularFunction	histone H3K27me2/H3K27me3 demethylase activity	KDM6B UTY	4.61e-04	5	137	2	GO:0071558
GeneOntologyMolecularFunction	ATP-activated inward rectifier potassium channel activity	ABCC9 ABCC8	6.88e-04	6	137	2	GO:0015272
GeneOntologyMolecularFunction	NAD+-protein poly-ADP-ribosyltransferase activity	PARP2 PARP1 PARP4	9.13e-04	28	137	3	GO:0003950
GeneOntologyMolecularFunction	clathrin light chain binding	NSG2 NSG1	9.59e-04	7	137	2	GO:0032051
GeneOntologyMolecularFunction	NAD+-protein ADP-ribosyltransferase activity	PARP2 PARP1 PARP4	1.12e-03	30	137	3	GO:1990404
GeneOntologyCellularComponent	potassium ion-transporting ATPase complex	ABCC9 ABCC8	1.31e-04	3	139	2	GO:0031004
GeneOntologyCellularComponent	trans-Golgi network	COG2 NBEA GPR108 NSG2 NSG1 FUT9 KIF13A RAB29 DOP1A	2.13e-04	306	139	9	GO:0005802
GeneOntologyCellularComponent	inward rectifying potassium channel	ABCC9 ABCC8	2.61e-04	4	139	2	GO:0008282
GeneOntologyCellularComponent	histone locus body	ICE2 ICE1	2.61e-04	4	139	2	GO:0035363
Domain	PARP_ALPHA_HD	PARP2 PARP1 PARP4	1.60e-06	4	139	3	PS51060
Domain	Poly(ADP-ribose)pol_reg_dom	PARP2 PARP1 PARP4	1.60e-06	4	139	3	IPR004102
Domain	-	PARP2 PARP1 PARP4	1.60e-06	4	139	3	1.20.142.10
Domain	DEP	GPR155 DVL1P1 DVL1 PLEK2	1.94e-05	22	139	4	PF00610
Domain	DEP	GPR155 DVL1P1 DVL1 PLEK2	1.94e-05	22	139	4	PS50186
Domain	DEP	GPR155 DVL1P1 DVL1 PLEK2	1.94e-05	22	139	4	SM00049
Domain	DEP_dom	GPR155 DVL1P1 DVL1 PLEK2	2.33e-05	23	139	4	IPR000591
Domain	Sulphorea_rcpt	ABCC9 ABCC8	5.50e-05	2	139	2	IPR000388
Domain	DVL-1	DVL1P1 DVL1	5.50e-05	2	139	2	IPR008340
Domain	Calcyon	NSG2 NSG1	1.64e-04	3	139	2	PF06387
Domain	WGR	PARP2 PARP1	1.64e-04	3	139	2	SM00773
Domain	PARP_reg	PARP2 PARP1	1.64e-04	3	139	2	PF02877
Domain	WGR	PARP2 PARP1	1.64e-04	3	139	2	PF05406
Domain	ORMDL	ORMDL3 ORMDL2	1.64e-04	3	139	2	IPR007203
Domain	ORMDL	ORMDL3 ORMDL2	1.64e-04	3	139	2	PF04061
Domain	Calcyon_neuron-sp	NSG2 NSG1	1.64e-04	3	139	2	IPR009431
Domain	TFIID-31	TAF9B TAF9	1.64e-04	3	139	2	IPR003162
Domain	TFIID-31kDa	TAF9B TAF9	1.64e-04	3	139	2	PF02291
Domain	-	PARP2 PARP1	1.64e-04	3	139	2	2.20.140.10
Domain	Poly(ADP-ribose)pol_cat_dom	PARP2 PARP1 PARP4	2.54e-04	17	139	3	IPR012317
Domain	PARP_CATALYTIC	PARP2 PARP1 PARP4	2.54e-04	17	139	3	PS51059
Domain	PARP	PARP2 PARP1 PARP4	2.54e-04	17	139	3	PF00644
Domain	-	PARP2 PARP1 PARP4	2.54e-04	17	139	3	3.90.228.10
Domain	Dishevelled	DVL1P1 DVL1	3.27e-04	4	139	2	PF02377
Domain	DNA_pol_B	POLD1 POLE	3.27e-04	4	139	2	PF00136
Domain	DNA-dir_DNA_pol_B	POLD1 POLE	3.27e-04	4	139	2	IPR006172
Domain	Dishevelled_fam	DVL1P1 DVL1	3.27e-04	4	139	2	IPR008339
Domain	DNA-dir_DNA_pol_B_exonuc	POLD1 POLE	3.27e-04	4	139	2	IPR006133
Domain	DNA-dir_DNA_pol_B_multi_dom	POLD1 POLE	3.27e-04	4	139	2	IPR006134
Domain	DNA_pol_B_exo1	POLD1 POLE	3.27e-04	4	139	2	PF03104
Domain	Dishevelled_protein_dom	DVL1P1 DVL1	3.27e-04	4	139	2	IPR003351
Domain	POLBc	POLD1 POLE	3.27e-04	4	139	2	SM00486
Domain	ABC_tran	ABCC9 ABCA8 ABCC8 ABCG2	4.43e-04	48	139	4	PF00005
Domain	ABC_TRANSPORTER_2	ABCC9 ABCA8 ABCC8 ABCG2	4.43e-04	48	139	4	PS50893
Domain	ABC_TRANSPORTER_1	ABCC9 ABCA8 ABCC8 ABCG2	4.80e-04	49	139	4	PS00211
Domain	ABC_transporter-like	ABCC9 ABCA8 ABCC8 ABCG2	5.19e-04	50	139	4	IPR003439
Domain	Anaphylatoxin_comp_syst	C4A C4B	5.42e-04	5	139	2	IPR018081
Domain	Anaphylatoxn_comp_syst_dom	C4A C4B	5.42e-04	5	139	2	IPR001840
Domain	Sushi	CSMD2 CR2 CSMD3 C4BPA	6.03e-04	52	139	4	PF00084
Domain	CCP	CSMD2 CR2 CSMD3 C4BPA	6.96e-04	54	139	4	SM00032
Domain	WGR_domain	PARP2 PARP1 PARP4	7.28e-04	24	139	3	IPR008893
Domain	SUSHI	CSMD2 CR2 CSMD3 C4BPA	7.99e-04	56	139	4	PS50923
Domain	-	TDRD15 SND1	8.09e-04	6	139	2	2.40.50.90
Domain	Staphylococal_nuclease_OB-fold	TDRD15 SND1	8.09e-04	6	139	2	IPR016071
Domain	Aminotrans_V_dom	KYNU MOCOS	8.09e-04	6	139	2	IPR000192
Domain	Aminotran_5	KYNU MOCOS	8.09e-04	6	139	2	PF00266
Domain	Sushi_SCR_CCP_dom	CSMD2 CR2 CSMD3 C4BPA	8.55e-04	57	139	4	IPR000436
Domain	ANATO	C4A C4B	1.13e-03	7	139	2	SM00104
Domain	ANAPHYLATOXIN_2	C4A C4B	1.13e-03	7	139	2	PS01178
Domain	ANAPHYLATOXIN_1	C4A C4B	1.13e-03	7	139	2	PS01177
Domain	ANATO	C4A C4B	1.13e-03	7	139	2	PF01821
Domain	DIX	DVL1P1 DVL1	1.13e-03	7	139	2	PF00778
Domain	DIX	DVL1P1 DVL1	1.13e-03	7	139	2	IPR001158
Domain	DIX	DVL1P1 DVL1	1.13e-03	7	139	2	PS50841
Domain	DAX	DVL1P1 DVL1	1.13e-03	7	139	2	SM00021
Domain	Anaphylatoxin/fibulin	C4A C4B	1.13e-03	7	139	2	IPR000020
Domain	Cadherin_CS	DCHS2 PCDHGB6 PCDHGB1 FAT1 PCDH15	1.34e-03	109	139	5	IPR020894
Domain	MacrogloblnA2_thiol-ester-bond	C4A C4B	1.50e-03	8	139	2	IPR019565
Domain	Thiol-ester_cl	C4A C4B	1.50e-03	8	139	2	PF10569
Domain	MacrogloblnA2_CS	C4A C4B	1.50e-03	8	139	2	IPR019742
Domain	CADHERIN_1	DCHS2 PCDHGB6 PCDHGB1 FAT1 PCDH15	1.57e-03	113	139	5	PS00232
Domain	Cadherin	DCHS2 PCDHGB6 PCDHGB1 FAT1 PCDH15	1.57e-03	113	139	5	PF00028
Domain	CADHERIN_2	DCHS2 PCDHGB6 PCDHGB1 FAT1 PCDH15	1.63e-03	114	139	5	PS50268
Domain	-	DCHS2 PCDHGB6 PCDHGB1 FAT1 PCDH15	1.63e-03	114	139	5	2.60.40.60
Domain	CA	DCHS2 PCDHGB6 PCDHGB1 FAT1 PCDH15	1.69e-03	115	139	5	SM00112
Domain	Cadherin-like	DCHS2 PCDHGB6 PCDHGB1 FAT1 PCDH15	1.76e-03	116	139	5	IPR015919
Domain	Cadherin	DCHS2 PCDHGB6 PCDHGB1 FAT1 PCDH15	1.90e-03	118	139	5	IPR002126
Domain	A2M	C4A C4B	2.38e-03	10	139	2	PF00207
Domain	A2M_N_2	C4A C4B	2.38e-03	10	139	2	IPR011625
Domain	A2M_comp	C4A C4B	2.38e-03	10	139	2	IPR011626
Domain	A2M_recep	C4A C4B	2.38e-03	10	139	2	PF07677
Domain	A2M_comp	C4A C4B	2.38e-03	10	139	2	PF07678
Domain	A2M_N	C4A C4B	2.38e-03	10	139	2	PF01835
Domain	A2M_N	C4A C4B	2.38e-03	10	139	2	IPR002890
Domain	A-macroglobulin_rcpt-bd	C4A C4B	2.38e-03	10	139	2	IPR009048
Domain	ALPHA_2_MACROGLOBULIN	C4A C4B	2.38e-03	10	139	2	PS00477
Domain	A2M_N_2	C4A C4B	2.38e-03	10	139	2	PF07703
Domain	Macroglobln_a2	C4A C4B	2.38e-03	10	139	2	IPR001599
Domain	Filamin	FLNC MYCBP2	2.89e-03	11	139	2	PF00630
Domain	FILAMIN_REPEAT	FLNC MYCBP2	2.89e-03	11	139	2	PS50194
Domain	DHR-1_domain	DOCK5 DOCK7	2.89e-03	11	139	2	IPR027007
Domain	DHR_2	DOCK5 DOCK7	2.89e-03	11	139	2	PS51651
Domain	DHR_1	DOCK5 DOCK7	2.89e-03	11	139	2	PS51650
Domain	DHR-2	DOCK5 DOCK7	2.89e-03	11	139	2	PF06920
Domain	Filamin/ABP280_rpt	FLNC MYCBP2	2.89e-03	11	139	2	IPR001298
Domain	Filamin/ABP280_repeat-like	FLNC MYCBP2	2.89e-03	11	139	2	IPR017868
Domain	DOCK	DOCK5 DOCK7	2.89e-03	11	139	2	IPR026791
Domain	HlyIII	PAQR8 PAQR5	2.89e-03	11	139	2	PF03006
Domain	DOCK_C	DOCK5 DOCK7	2.89e-03	11	139	2	IPR010703
Domain	DOCK-C2	DOCK5 DOCK7	2.89e-03	11	139	2	PF14429
Domain	DHR-2	DOCK5 DOCK7	2.89e-03	11	139	2	IPR027357
Domain	AdipoR/HlyIII-related	PAQR8 PAQR5	2.89e-03	11	139	2	IPR004254
Domain	Rho_GTPase_activation_prot	STARD13 PLXNA3 ARHGAP5 SRGAP1	4.23e-03	88	139	4	IPR008936
Domain	TUDOR	TDRD15 SND1	4.72e-03	14	139	2	PF00567
Domain	Myosin_N	MYH2 MYH8	5.42e-03	15	139	2	PF02736
Domain	Myosin_N	MYH2 MYH8	5.42e-03	15	139	2	IPR004009
Domain	C345C	C4A C4B	6.95e-03	17	139	2	SM00643
Pathway	KEGG_BASE_EXCISION_REPAIR	POLD1 POLE PARP2 PARP1 PARP4	6.80e-06	35	109	5	M5500
Pathway	REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY	POLD1 POLE PARP2 PARP1	3.77e-05	25	109	4	M541
Pathway	REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY	POLD1 POLE PARP2 PARP1	4.43e-05	26	109	4	MM14481
Pathway	WP_BASE_EXCISION_REPAIR	POLD1 POLE PARP2 PARP1	9.06e-05	31	109	4	M39861
Pathway	REACTOME_HDR_THROUGH_MMEJ_ALT_NHEJ	PARP2 PARP1 BRCA2	9.40e-05	12	109	3	M27569
Pathway	REACTOME_HDR_THROUGH_MMEJ_ALT_NHEJ	PARP2 PARP1 BRCA2	9.40e-05	12	109	3	MM15282
Pathway	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	CR2 F5 C4A C4B C4BPA	1.91e-04	69	109	5	M16894
Pathway	REACTOME_RESOLUTION_OF_ABASIC_SITES_AP_SITES	POLD1 POLE PARP2 PARP1	2.04e-04	38	109	4	M27701
Pathway	REACTOME_RESOLUTION_OF_ABASIC_SITES_AP_SITES	POLD1 POLE PARP2 PARP1	2.26e-04	39	109	4	MM17222
Pathway	REACTOME_DUAL_INCISION_IN_GG_NER	POLD1 POLE PARP2 PARP1	2.75e-04	41	109	4	M27595
Pathway	REACTOME_DUAL_INCISION_IN_GG_NER	POLD1 POLE PARP2 PARP1	3.02e-04	42	109	4	MM15306
Pathway	KEGG_ABC_TRANSPORTERS	ABCC9 ABCA8 ABCC8 ABCG2	3.62e-04	44	109	4	M11911
Pubmed	Transmission of antibody-induced arthritis is independent of complement component 4 (C4) and the complement receptors 1 and 2 (CD21/35).	CR2 C4A C4B	6.52e-08	3	141	3	11857338
Pubmed	Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2.	CR2 C4A C4B	2.60e-07	4	141	3	11067882
Pubmed	Antigen localization within the splenic marginal zone restores humoral immune response and IgG class switch in complement C4-deficient mice.	CR2 C4A C4B	2.60e-07	4	141	3	15477230
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	MIA3 POLE SIN3A DICER1 DOCK5 PARP4 TMEM62 TBK1 DOCK7 C4A C4B HSD17B4 KYNU MOCOS	4.52e-07	650	141	14	38777146
Pubmed	Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia.	CR2 C4A C4B	6.48e-07	5	141	3	15192652
Pubmed	Protective T cell-independent antiviral antibody responses are dependent on complement.	CR2 C4A C4B	6.48e-07	5	141	3	10523614
Pubmed	Stromal complement receptor CD21/35 facilitates lymphoid prion colonization and pathogenesis.	CR2 C4A C4B	6.48e-07	5	141	3	17947689
Pubmed	Poly(ADP-ribose) polymerases PARP1 and PARP2 modulate topoisomerase II beta (TOP2B) function during chromatin condensation in mouse spermiogenesis.	PARP2 PARP1 TOP2B	6.48e-07	5	141	3	21228215
Pubmed	CD21/35 promotes protective immunity to Streptococcus pneumoniae through a complement-independent but CD19-dependent pathway that regulates PD-1 expression.	CR2 C4A C4B	1.29e-06	6	141	3	19710450
Pubmed	Constitutive expression of TNF-alpha and -beta genes in mouse embryo: roles of cytokines as regulator and effector on development.	CR2 C4A C4B IL1A	1.47e-06	21	141	4	8138038
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	COPA ICE1 DICER1 DOCK5 PARP4 PI4KA DOCK7 TOP2B	1.84e-06	202	141	8	33005030
Pubmed	Antibodies and complement are key drivers of thrombosis.	CR2 ITGAX C4A C4B	2.16e-06	23	141	4	39226900
Pubmed	Identification of 18 mouse ABC genes and characterization of the ABC superfamily in Mus musculus.	ABCC9 ABCA8 ABCC8 ABCG2	2.16e-06	23	141	4	10708515
Pubmed	Mapping specific protein-protein interactions within the core component of the breast cell DNA synthesome.	POLD1 POLE PARP1	2.26e-06	7	141	3	9563011
Pubmed	Divergent immunoglobulin g subclass activity through selective Fc receptor binding.	CR2 C4A C4B	3.60e-06	8	141	3	16322460
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	COG2 DCHS2 WASHC4 COPA MYCBP2 USP9X ENC1 NBEA KDM6B ZNF181 TXNDC11 ARHGAP5 PARP1 RORB CTNND2 ZNF606 HSD17B4 AGTPBP1	4.87e-06	1285	141	18	35914814
Pubmed	Constitutive and interleukin-1-inducible phosphorylation of p65 NF-{kappa}B at serine 536 is mediated by multiple protein kinases including I{kappa}B kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription.	TBK1 TAF9 IL1A	5.38e-06	9	141	3	15489227
Pubmed	Small molecule inhibitors uncover synthetic genetic interactions of human flap endonuclease 1 (FEN1) with DNA damage response genes.	PARP2 PARP1 BRCA2	5.38e-06	9	141	3	28628639
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	FLNC COPA USP9X POLD1 PI4KA DOCK7 CPSF1 WDR82 ABCG2	5.71e-06	313	141	9	38270169
Pubmed	CLEC16A interacts with retromer and TRIM27, and its loss impairs endosomal trafficking and neurodevelopment.	COG2 MYCBP2 POLD1 POLE HM13 NDUFS8 PARP4 BRCA2 PI4KA TBK1 CPSF1 TAF9	7.28e-06	606	141	12	36538041
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	LAMB4 MUC19 NBEA ICE1 CSMD2 NUP205 DOCK5 ARHGAP5 PARP4 PI4KA TBK1 CCDC87 CPSF1	1.02e-05	736	141	13	29676528
Pubmed	Genetic variation in the base excision repair pathway and bladder cancer risk.	POLD1 PARP1 PARP4	1.40e-05	12	141	3	17203305
Pubmed	Copy number analysis of complement C4A, C4B and C4A silencing mutation by real-time quantitative polymerase chain reaction.	C4A C4B	1.63e-05	2	141	2	22737222
Pubmed	Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection.	C4A C4B	1.63e-05	2	141	2	16565498
Pubmed	Complete deficiencies of complement C4A and C4B including 2-bp insertion in codon 1213 are genetic risk factors of systemic lupus erythematosus in Thai populations.	C4A C4B	1.63e-05	2	141	2	15998580
Pubmed	High-throughput analysis of the C4 polymorphism by a combination of MLPA and isotype-specific ELISA's.	C4A C4B	1.63e-05	2	141	2	19062096
Pubmed	Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice.	C4A C4B	1.63e-05	2	141	2	19933335
Pubmed	Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4.	C4A C4B	1.63e-05	2	141	2	2459207
Pubmed	Antigen-induced B cell apoptosis is independent of complement C4.	C4A C4B	1.63e-05	2	141	2	17645767
Pubmed	Combined mismatch repair and POLE/POLD1 defects explain unresolved suspected Lynch syndrome cancers.	POLD1 POLE	1.63e-05	2	141	2	26648449
Pubmed	Anti-DNA autoreactivity in C4-deficient mice.	C4A C4B	1.63e-05	2	141	2	12207352
Pubmed	Poly(ADP-Ribose) Polymerases: New Players in the Pathogenesis of Exocrine Pancreatic Diseases.	PARP2 PARP1	1.63e-05	2	141	2	26687988
Pubmed	Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients.	C4A C4B	1.63e-05	2	141	2	27758680
Pubmed	Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations.	C4A C4B	1.63e-05	2	141	2	22387014
Pubmed	Hypoxia-inducible factor-2alpha transactivates Abcg2 and promotes cytoprotection in cardiac side population cells.	ABCG2 EPAS1	1.63e-05	2	141	2	18356544
Pubmed	Polymerase proofreading-associated polyposis: a new, dominantly inherited syndrome of hereditary colorectal cancer predisposition.	POLD1 POLE	1.63e-05	2	141	2	24509466
Pubmed	Increased somatic mutation burdens in normal human cells due to defective DNA polymerases.	POLD1 POLE	1.63e-05	2	141	2	34594041
Pubmed	Molecular determinants of ATP-sensitive potassium channel MgATPase activity: diabetes risk variants and diazoxide sensitivity.	ABCC9 ABCC8	1.63e-05	2	141	2	26181369
Pubmed	Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner.	C4A C4B	1.63e-05	2	141	2	23749435
Pubmed	Copy number variations of complement component C4 are associated with Behçet's disease but not with ankylosing spondylitis associated with acute anterior uveitis.	C4A C4B	1.63e-05	2	141	2	23918728
Pubmed	Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein.	C4A C4B	1.63e-05	2	141	2	3037333
Pubmed	Long patch base excision repair with purified human proteins. DNA ligase I as patch size mediator for DNA polymerases delta and epsilon.	POLD1 POLE	1.63e-05	2	141	2	10559260
Pubmed	Evidence of a role for C4 in modulating interstitial inflammation in experimental glomerulonephritis.	C4A C4B	1.63e-05	2	141	2	11726230
Pubmed	Quantitative variations in the expression of the mouse serum antigen Ss and its sex-limited allotype Slp.	C4A C4B	1.63e-05	2	141	2	4216347
Pubmed	Sequence determination of the thiolester site of the fourth component of human complement.	C4A C4B	1.63e-05	2	141	2	6950384
Pubmed	ORMDL2 Deficiency Potentiates the ORMDL3-Dependent Changes in Mast Cell Signaling.	ORMDL3 ORMDL2	1.63e-05	2	141	2	33643282
Pubmed	Visual demonstration of the organization of the human complement C4 and 21-hydroxylase genes by high-resolution fluorescence in situ hybridization.	C4A C4B	1.63e-05	2	141	2	8660986
Pubmed	Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain.	C4A C4B	1.63e-05	2	141	2	8428773
Pubmed	Identification of a novel gene (ADPRTL1) encoding a potential Poly(ADP-ribosyl)transferase protein.	PARP2 PARP4	1.63e-05	2	141	2	10644454
Pubmed	Involvement of HIV-1 protease in virus-induced cell killing.	PARP1 PARP4	1.63e-05	2	141	2	15781132
Pubmed	Complement C4 deficiency--a plausible risk factor for non-tuberculous mycobacteria (NTM) infection in apparently immunocompetent patients.	C4A C4B	1.63e-05	2	141	2	24638111
Pubmed	Transcriptional repression of C4 complement by hepatitis C virus proteins.	C4A C4B	1.63e-05	2	141	2	21345967
Pubmed	Role of POLE and POLD1 in familial cancer.	POLD1 POLE	1.63e-05	2	141	2	32792570
Pubmed	Single-molecule force spectroscopy reveals binding and bridging dynamics of PARP1 and PARP2 at DNA double-strand breaks.	PARP2 PARP1	1.63e-05	2	141	2	37216533
Pubmed	Poly(ADP-ribose) reactivates stalled DNA topoisomerase I and Induces DNA strand break resealing.	PARP2 PARP1	1.63e-05	2	141	2	14699148
Pubmed	Restriction fragment analysis of H-2 recombinant mouse strains with crossovers between E alpha and C4 genes.	C4A C4B	1.63e-05	2	141	2	2572548
Pubmed	The complement component C4 of mammals.	C4A C4B	1.63e-05	2	141	2	2302180
Pubmed	Human mismatch repair system balances mutation rates between strands by removing more mismatches from the lagging strand.	POLD1 POLE	1.63e-05	2	141	2	28512192
Pubmed	MicroRNA expression and protein acetylation pattern in respiratory and limb muscles of Parp-1(-/-) and Parp-2(-/-) mice with lung cancer cachexia.	PARP2 PARP1	1.63e-05	2	141	2	26432600
Pubmed	Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse.	PARP2 PARP1	1.63e-05	2	141	2	12727891
Pubmed	Gene CNVs and protein levels of complement C4A and C4B as novel biomarkers for partial disease remissions in new-onset type 1 diabetes patients.	C4A C4B	1.63e-05	2	141	2	22151770
Pubmed	C4d-positive chronic rejection: a frequent entity with a poor outcome.	C4A C4B	1.63e-05	2	141	2	18091514
Pubmed	Comprehensive approach to study complement C4 in systemic lupus erythematosus: Gene polymorphisms, protein levels and functional activity.	C4A C4B	1.63e-05	2	141	2	29080553
Pubmed	Genes for murine fourth complement component (C4) and sex-limited protein (Slp) identified by hybridization to C4- and Slp-specific cDNA.	C4A C4B	1.63e-05	2	141	2	6589636
Pubmed	C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production.	C4A C4B	1.63e-05	2	141	2	25339671
Pubmed	Feedback-regulated poly(ADP-ribosyl)ation by PARP-1 is required for rapid response to DNA damage in living cells.	PARP2 PARP1	1.63e-05	2	141	2	17982172
Pubmed	A study of association of the complement C4 mutations with systemic lupus erythematosus in the Malaysian population.	C4A C4B	1.63e-05	2	141	2	17728371
Pubmed	Germline and somatic polymerase ε and δ mutations define a new class of hypermutated colorectal and endometrial cancers.	POLD1 POLE	1.63e-05	2	141	2	23447401
Pubmed	Poly(ADP-ribose) polymerases covalently modify strand break termini in DNA fragments in vitro.	PARP2 PARP1	1.63e-05	2	141	2	27471034
Pubmed	PARP2 deficiency affects invariant-NKT-cell maturation and protects mice from concanavalin A-induced liver injury.	PARP2 PARP1	1.63e-05	2	141	2	28751426
Pubmed	Structure and organization of the C4 genes.	C4A C4B	1.63e-05	2	141	2	6149580
Pubmed	Sequence heterogeneity of murine complementary DNA clones related to the C4 and C4-Slp isoforms of the fourth complement component.	C4A C4B	1.63e-05	2	141	2	6149581
Pubmed	The follicular dendritic cell restricted epitope, FDC-M2, is complement C4; localization of immune complexes in mouse tissues.	C4A C4B	1.63e-05	2	141	2	12115608
Pubmed	Biochemistry and biology of anaphylatoxins.	C4A C4B	1.63e-05	2	141	2	3542363
Pubmed	C4 from C4-high and C4-low mouse strains have identical sequences in the region corresponding to the isotype-specific segment of human C4.	C4A C4B	1.63e-05	2	141	2	2387317
Pubmed	Role of PARP-1 and PARP-2 in the expression of apoptosis-regulating genes in HeLa cells.	PARP2 PARP1	1.63e-05	2	141	2	18587655
Pubmed	In vivo functional analysis of the histone 3-like TAF9 and a TAF9-related factor, TAF9L.	TAF9B TAF9	1.63e-05	2	141	2	12837753
Pubmed	Tumor-Infiltrating Lymphocytes, Tumor Mutational Burden, and Genetic Alterations in Microsatellite Unstable, Microsatellite Stable, or Mutant POLE/POLD1 Colon Cancer.	POLD1 POLE	1.63e-05	2	141	2	34250404
Pubmed	Identification of the size and antigenic determinants of the human C4 gene by a polymerase chain-reaction-based amplification method.	C4A C4B	1.63e-05	2	141	2	16908004
Pubmed	Structural studies on the murine fourth component of complement (C4). IV. Demonstration that C4 and Slp are encoded by separate loci.	C4A C4B	1.63e-05	2	141	2	7365238
Pubmed	Interaction between the labile binding sites of the fourth (C4) and fifth (C5) human complement proteins and erythrocyte cell membranes.	C4A C4B	1.63e-05	2	141	2	7391573
Pubmed	Peritubular capillary C4d deposition in lupus nephritis different from antibody-mediated renal rejection.	C4A C4B	1.63e-05	2	141	2	17971360
Pubmed	Clinical features of patients with homozygous complement C4A or C4B deficiency.	C4A C4B	1.63e-05	2	141	2	29928053
Pubmed	Analysis of C4 and the C4 binding protein in the MRL/lpr mouse.	C4A C4B	1.63e-05	2	141	2	17971229
Pubmed	Genetic deficiency of C4 presenting with recurrent infections and a SLE-like disease. Genetic and immunologic studies.	C4A C4B	1.63e-05	2	141	2	6881182
Pubmed	Dicer-mediated upregulation of BCRP confers tamoxifen resistance in human breast cancer cells.	DICER1 ABCG2	1.63e-05	2	141	2	21878538
Pubmed	Genetic ablation of PARP-1 protects against oxazolone-induced contact hypersensitivity by modulating oxidative stress.	PARP2 PARP1	1.63e-05	2	141	2	20613774
Pubmed	Partial C4 deficiency in juvenile idiopathic arthritis patients.	C4A C4B	1.63e-05	2	141	2	17921792
Pubmed	Complement activation and complement receptors on follicular dendritic cells are critical for the function of a targeted adjuvant.	C4A C4B	1.63e-05	2	141	2	21880985
Pubmed	Amino acid sequence around the thiol and reactive acyl groups of human complement component C4.	C4A C4B	1.63e-05	2	141	2	6978711
Pubmed	Plasma Complement 3 and Complement 4 Are Promising Biomarkers for Distinguishing NMOSD From MOGAD and Are Associated With the Blood-Brain-Barrier Disruption in NMOSD.	C4A C4B	1.63e-05	2	141	2	35898513
Pubmed	Borrelia burgdorferi outer surface protein C (OspC) binds complement component C4b and confers bloodstream survival.	C4A C4B	1.63e-05	2	141	2	28873507
Pubmed	POLE/POLD1 mutation in non-exonuclease domain matters for predicting efficacy of immune-checkpoint-inhibitor therapy.	POLD1 POLE	1.63e-05	2	141	2	34586735
Pubmed	Mutation spectrum of POLE and POLD1 mutations in South East Asian women presenting with grade 3 endometrioid endometrial carcinomas.	POLD1 POLE	1.63e-05	2	141	2	26748215
Pubmed	Studies on the murine Ss protein: demonstration that the Ss protein is functionally the fourth component of complement.	C4A C4B	1.63e-05	2	141	2	276882
Pubmed	Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4.	C4A C4B	1.63e-05	2	141	2	6832377
Pubmed	Reduced tumor burden through increased oxidative stress in lung adenocarcinoma cells of PARP-1 and PARP-2 knockout mice.	PARP2 PARP1	1.63e-05	2	141	2	26700152
Pubmed	PARP-2 deficiency affects the survival of CD4+CD8+ double-positive thymocytes.	PARP2 PARP1	1.63e-05	2	141	2	16946705
Pubmed	Recombination of two homologous MHC class III genes of the mouse (C4 and Slp) that accounts for the loss of testosterone dependence of sex-limited protein expression.	C4A C4B	1.63e-05	2	141	2	3794341
Pubmed	Human homologue sequences to the Drosophila dishevelled segment-polarity gene are deleted in the DiGeorge syndrome.	DVL1P1 DVL1	1.63e-05	2	141	2	8644734
Interaction	TAF13 interactions	POLD1 PARP1 TAF9B CPSF1 TAF9	5.46e-06	38	136	5	int:TAF13
Interaction	LRRC31 interactions	COPA ICE1 DICER1 DOCK5 PARP1 PARP4 PI4KA DOCK7 TOP2B	1.07e-05	205	136	9	int:LRRC31
Interaction	SORT1 interactions	MIA3 COPA ICE2 DICER1 TXNDC11 UTP15 PI4KA CSPG4 HSD17B4	1.21e-05	208	136	9	int:SORT1
GeneFamily	Complement system\|Sushi domain containing	CR2 ITGAX C4A C4B	3.70e-05	36	95	4	492
GeneFamily	Cadherin related	DCHS2 FAT1 PCDH15	9.06e-05	17	95	3	24
GeneFamily	Zinc fingers\|Zinc fingers PARP-type\|Poly(ADP-ribose) polymerases	PARP2 PARP1 PARP4	9.06e-05	17	95	3	684
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	CSMD2 CR2 CSMD3 C4BPA	2.28e-04	57	95	4	1179
GeneFamily	Glycosyltransferase family 6\|Blood group antigens	C4A C4B ABCG2	9.59e-04	37	95	3	454
GeneFamily	C3 and PZP like, alpha-2-macroglobulin domain containing	C4A C4B	9.60e-04	9	95	2	1234
GeneFamily	Progestin and adipoQ receptor family	PAQR8 PAQR5	1.46e-03	11	95	2	930
GeneFamily	ATP binding cassette subfamily C	ABCC9 ABCC8	2.05e-03	13	95	2	807
GeneFamily	Rho GTPase activating proteins\|BCH domain containing	STARD13 ARHGAP5 SRGAP1	2.30e-03	50	95	3	721
GeneFamily	Myosin heavy chains	MYH2 MYH8	2.74e-03	15	95	2	1098
GeneFamily	Protein tyrosine phosphatases, receptor type	PTPRG PTPRJ	5.38e-03	21	95	2	813
GeneFamily	DNA polymerases	POLD1 POLE	6.43e-03	23	95	2	535
GeneFamily	PHD finger proteins\|Lysine demethylases	KDM6B UTY	6.99e-03	24	95	2	485
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	GPR155 PLXNA3 MIA3 MYCBP2 ENC1 PAQR8 MUC19 NBEA GRIK2 SIN3A CSMD2 CSMD3 DICER1 NSG2 CSRNP3 SV2B SRGAP1 NSG1 FUT9 CTNND2 KIF13A ZMAT1 HYDIN AGTPBP1 DOP1A	8.01e-10	1106	139	25	M39071
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBGABA	GPR155 MYCBP2 ENC1 PAQR8 MUC19 NBEA GRIK2 CSMD2 CSMD3 DICER1 NSG2 CSRNP3 SV2B NSG1 DOP1A	5.20e-06	703	139	15	M39070
CoexpressionAtlas	kidney_adult_Podocyte_MafB_top-relative-expression-ranked_500	NEBL SGK3 DOCK5 PLEKHG1 ARHGAP5 PARP4 FAT1 CLIC5 TAF9B PTPRJ SRGAP1 PLEKHH2	3.24e-05	445	137	12	gudmap_kidney_adult_Podocyte_MafB_500
CoexpressionAtlas	kidney_adult_RenCorpuscGlomer_k-means-cluster#3_top-relative-expression-ranked_500	NEBL DOCK5 PLEKHG1 CLIC5 PTPRJ SRGAP1 PLEKHH2	3.68e-05	141	137	7	gudmap_kidney_adult_RenCorpuscGlomer_k3_500
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MYH2 HECW1 POLE CSMD3 F5 PKHD1L1 PCDH15 FUT9 HYDIN	2.38e-09	162	140	9	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HECW1 CSMD2 CSMD3 ABCC8 CSPG4 PCDH15 PLEKHH2 KIF13A HYDIN	1.44e-08	199	140	9	19a97e27a4758e794ce7246d295e112b47931a48
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH2 MYH8 HECW1 POLE CSMD3 PCDH15 FUT9 HYDIN	2.00e-08	145	140	8	96712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH8 MUC19 GRIK2 PKHD1L1 ADCY8 PTPRG PLEKHH2 HYDIN	4.30e-08	160	140	8	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH8 MUC19 GRIK2 PKHD1L1 ADCY8 PTPRG PLEKHH2 HYDIN	4.30e-08	160	140	8	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYH8 ENC1 SLC3A1 PARP4 FAT1 FUT9 PLEKHH2 HYDIN	1.83e-07	193	140	8	ffa1932da2979d7b63dbac32eb5788346a3f5b2a
ToppCell	Macroglial-Polydendrocytes-PDGFRA-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	HECW1 GRIK2 CSMD2 CSMD3 CSRNP3 CSPG4 PCDH15 PLEKHH2	2.40e-07	200	140	8	f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2
ToppCell	Macroglial-Polydendrocytes-PDGFRA--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	HECW1 GRIK2 CSMD2 CSMD3 CSRNP3 CSPG4 PCDH15 PLEKHH2	2.40e-07	200	140	8	cc3409518f8b436ea92deb955e81114b3f410ff7
ToppCell	Macroglial-Polydendrocytes-PDGFRA\|Macroglial / cells hierarchy compared to all cells using T-Statistic	HECW1 GRIK2 CSMD2 CSMD3 CSRNP3 CSPG4 PCDH15 PLEKHH2	2.40e-07	200	140	8	c24a3099e3d96d8b72f6d05286bb355d661a0377
ToppCell	Macroglial-Polydendrocytes-PDGFRA---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	HECW1 GRIK2 CSMD2 CSMD3 CSRNP3 CSPG4 PCDH15 PLEKHH2	2.40e-07	200	140	8	4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca
ToppCell	Macroglial-Polydendrocytes-PDGFRA----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	HECW1 GRIK2 CSMD2 CSMD3 CSRNP3 CSPG4 PCDH15 PLEKHH2	2.40e-07	200	140	8	310cd53db1c137f6af74e6ae682221d7ac27310c
ToppCell	Macroglial-Polydendrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	HECW1 GRIK2 CSMD2 CSMD3 CSRNP3 CSPG4 PCDH15 PLEKHH2	2.40e-07	200	140	8	961858738ce35db8760c8c2e136f8369bc444ccf
ToppCell	CV-Mild-7\|CV / Virus stimulation, Condition and Cluster	WASHC4 ICE2 NUP205 ZNF606 HSD17B4 DOP1A ANKS1A	1.14e-06	170	140	7	25ebde7d2f8ae1afdfaf5876284ff20bb179eb10
ToppCell	COVID-19-Heart-Neuronal\|Heart / Disease (COVID-19 only), tissue and cell type	STARD13 GPR155 TRABD2B GRIK2 DOCK5 PTPRJ CTNND2	1.29e-06	173	140	7	6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	LAMB4 MUC19 CNTLN CSMD3 SRGAP1 RORB AGTPBP1	2.08e-06	186	140	7	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FLNC EPGN PKHD1L1 ABCA8 TINAG C4A C4B	2.08e-06	186	140	7	7812ed80d2378aca9957ef22fc3c8fb7fb58434b
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HECW1 NEBL CSMD2 NSG2 SV2B RORB PLEKHH2	2.85e-06	195	140	7	787e95fb59c40bba784544b662fac37606ae1427
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRABD2B NEBL PAQR5 SLC3A1 FAT1 PTPRJ HYDIN	2.95e-06	196	140	7	6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0
ToppCell	Biopsy_IPF-Mesenchymal-Mesothelial_cells\|Biopsy_IPF / Sample group, Lineage and Cell type	FLNC EPGN PKHD1L1 ABCA8 NSG1 C4A C4B	3.37e-06	200	140	7	553386523fd8f8f36617a0d81032224b7ddce442
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NEBL ADCY8 PARP4 FUT9 PLEKHH2 HYDIN	4.79e-06	137	140	6	0aa4e14b32da0cda677cc0ed6ae470f6ecd77bea
ToppCell	facs-Marrow-KLS-18m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPR155 TRABD2B PAQR5 ITGAX CTNND2 KYNU	1.05e-05	157	140	6	5d08ff0ba9d3df9cc30f13cab2d2b395ea6f3446
ToppCell	facs-Marrow-KLS-18m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPR155 TRABD2B PAQR5 ITGAX CTNND2 KYNU	1.05e-05	157	140	6	ad9c9b7dfeee3ae46e7e593c51a0407df12195b4
ToppCell	PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ITGAX F5 ACOD1 FUT9 C4B IL1A	1.09e-05	158	140	6	bdfa3aa1ffc025d846f14ccb3ca84d889916021f
ToppCell	PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-AM\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ITGAX F5 ACOD1 FUT9 C4B IL1A	1.25e-05	162	140	6	16d625ac6702f79a83af444d2b3bf6759fd17cf6
ToppCell	LV-16._Neuronal\|World / Chamber and Cluster_Paper	GPR155 TRABD2B GRIK2 ABCA8 DOCK5 PTPRJ	1.39e-05	165	140	6	6ed52cb756d21addf46c7f6c457458b01339fe04
ToppCell	COVID-19-Heart-Neuronal\|COVID-19 / Disease (COVID-19 only), tissue and cell type	STARD13 GPR155 GRIK2 ABCA8 DOCK5 CTNND2	1.54e-05	168	140	6	88c2c574f428c2502b5fe099bd73b0758f668ef6
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CSMD3 PKHD1L1 CSRNP3 PCDH15 C4B HYDIN	1.59e-05	169	140	6	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	droplet-Fat-Scat-21m-Endothelial-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEBL PLEKHG1 CLIC5 BRCA2 ABCG2 EPAS1	1.82e-05	173	140	6	f13124b4cf2ac1dc2895f90f5487d6ac681b0ba4
ToppCell	CV-Mild-7\|Mild / Virus stimulation, Condition and Cluster	WASHC4 ICE2 NUP205 PLEKHG1 DOP1A ANKS1A	1.82e-05	173	140	6	c9bbca9313a0fdf146c8c995624b94b937e818d8
ToppCell	facs-Diaphragm-Limb_Muscle-24m-Mesenchymal\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNC CSMD3 PKHD1L1 PCDH15 C4B HYDIN	1.82e-05	173	140	6	66f37c1437705734b20601656fa4aa1d92ca30be
ToppCell	facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-nan\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNC CSMD3 PKHD1L1 PCDH15 C4B HYDIN	1.82e-05	173	140	6	649b08a409095592cccf31883be69c754411280d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NEBL PARP4 FAT1 FUT9 PLEKHH2 HYDIN	2.00e-05	176	140	6	327a3e81b724252e36d786de92a3ffd721ea6d7b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NEBL GRIK2 F5 DOCK5 CLIC5 SRGAP1	2.07e-05	177	140	6	4d2cdb57b427a42085c5f9affa0967b15e84dec3
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NEBL GRIK2 F5 DOCK5 CLIC5 SRGAP1	2.13e-05	178	140	6	edc7143dc9959d36057cb9471681a23afcbc8cce
ToppCell	droplet-Marrow-nan-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PAQR5 ITGAX STAT2 ARHGAP5 CTNND2 KYNU	2.27e-05	180	140	6	64f01494a4052186773720e10b4e7c724ff94547
ToppCell	RA-16._Neuronal\|World / Chamber and Cluster_Paper	GPR155 TRABD2B PAQR8 GRIK2 DOCK5 PTPRJ	2.34e-05	181	140	6	7d22a43f887e0747f0cb87ba364ff27905ee6eec
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NEBL PARP4 FAT1 FUT9 PLEKHH2 HYDIN	2.42e-05	182	140	6	5e1b316599436740f1b30875f0ebd33c3edfb2b6
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 MYH8 MUC19 ADCY8 SLC3A1 TINAG	2.49e-05	183	140	6	d73cac83cde82665f110baad7cf28db75f9ffe52
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NEBL GRIK2 F5 DOCK5 CLIC5 SRGAP1	2.49e-05	183	140	6	848fc6dd129150897ee339343e83c645b6e779eb
ToppCell	B_cells-ISG-high_B_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	CR2 STAT2 PLEKHG1 BRCA2 BTK DOP1A	2.49e-05	183	140	6	dc2b00e920efa1dcc2a6265cd1024e3249c9974f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NEBL GRIK2 F5 DOCK5 CLIC5 SRGAP1	2.49e-05	183	140	6	eb559ae3ae252d9365c24ef557dd49b78ed6d898
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NEBL GRIK2 F5 DOCK5 CLIC5 SRGAP1	2.49e-05	183	140	6	7c4b775f351794a3de06bd503eecbc8ae8577c44
ToppCell	AT1-AT2_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	STARD13 NEBL ABCA8 CLIC5 CTNND2 PLEKHH2	2.49e-05	183	140	6	6821dca076318115d360ff426eb1218cfe104063
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HECW1 CSMD3 PKHD1L1 FAT1 PCDH15 HYDIN	2.57e-05	184	140	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MUC19 CSMD3 ITGAX F5 C4BPA CTNND2	2.57e-05	184	140	6	7ecdf2645e9378cf2f5ce4557f2cf100e6f184ba
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	MYCBP2 ABCC9 ABCA8 PTPRG CSRNP3 RORB	2.57e-05	184	140	6	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HECW1 CSMD3 PKHD1L1 FAT1 PCDH15 HYDIN	2.57e-05	184	140	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HECW1 CSMD3 PKHD1L1 FAT1 PCDH15 HYDIN	2.57e-05	184	140	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NEBL GRIK2 F5 DOCK5 CLIC5 PLEKHH2	2.57e-05	184	140	6	7294b379ce4cb8fa75e432559082f93cd106aaf5
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NEBL GRIK2 F5 DOCK5 CLIC5 SRGAP1	2.65e-05	185	140	6	9197f074e769d54031ec41abfc65fcc0c6552c7e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NEBL GRIK2 F5 DOCK5 CLIC5 SRGAP1	2.65e-05	185	140	6	ce7d62394b09c26ca65b8cdb280afec5e25bbb62
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NEBL GRIK2 F5 DOCK5 CLIC5 SRGAP1	2.65e-05	185	140	6	b848b63aff4d9dbb9e66a85876d4c7c6dacd0579
ToppCell	LPS-antiTNF-Myeloid\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ITGAX ACOD1 DOCK5 PTPRJ IL1A KYNU	2.73e-05	186	140	6	839c6da5244f469461b2e5563e36162b2911cd01
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NEBL PARP4 FAT1 FUT9 PLEKHH2 HYDIN	2.99e-05	189	140	6	904b8337e2cabac2f0bf5dad5598fc429581ed81
ToppCell	COVID-19-Heart\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FLNC ABCC9 ABCA8 CLIC5 PTPRG CTNND2	3.08e-05	190	140	6	918ad5037881212008f9f69d5df5da91fd01422c
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	GPR155 GRIK2 CSMD3 CSPG4 PCDH15 KIF13A	3.08e-05	190	140	6	6c7e1086c0a274cd5527c3104106e372811c9905
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NEBL PARP4 FAT1 FUT9 PLEKHH2 HYDIN	3.17e-05	191	140	6	d0e9afe7b6334dd515d3e68892efdc76347a55e5
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	NEBL ENC1 PAQR5 DOCK5 FAT1 PTPRG	3.26e-05	192	140	6	4c9d748f209cc1e13d28c8c7f5180ab8522e0fbf
ToppCell	facs-Aorta-Heart-3m\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CAB39 USP9X PARP1 PTPRG HYDIN TOP2B	3.26e-05	192	140	6	1ccc47792edf9ee23501c8e2165d11271636b66a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRABD2B NEBL PAQR5 SLC3A1 TINAG PTPRJ	3.36e-05	193	140	6	82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRABD2B NEBL PAQR5 FAT1 TINAG PTPRJ	3.36e-05	193	140	6	3866667dd221612589ae50f5c52f73a183a49ce6
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CSMD3 ABCA8 PTPRG SRGAP1 PCDH15 PLEKHH2	3.46e-05	194	140	6	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NEBL PAQR5 SLC3A1 FAT1 PTPRJ HYDIN	3.46e-05	194	140	6	93c68c31e39fa44c1d05d7d4997f4f086da4e738
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	NEBL ENC1 PAQR5 DOCK5 FAT1 NSG1	3.46e-05	194	140	6	fb80a0271ccb1cb3f954ebcf2c5945cb6adb6b8c
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	NEBL ABCA8 PTPRG SRGAP1 PCDH15 PLEKHH2	3.56e-05	195	140	6	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MIA3 MYCBP2 USP9X NBEA ABCC8 UTY	3.56e-05	195	140	6	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MIA3 MYCBP2 USP9X NBEA ABCC8 UTY	3.56e-05	195	140	6	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	COPD-Endothelial-VE_Capillary_B\|Endothelial / Disease state, Lineage and Cell class	STARD13 PTPRG ABCC8 PCDH15 EPAS1 ANKS1A	3.76e-05	197	140	6	30dbc05ea66892d2e18ff375ffa86d1db7bc4083
ToppCell	Parenchymal-10x5prime-Stromal-Mesofibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	GRIK2 EPGN PKHD1L1 ABCA8 C4A C4B	3.76e-05	197	140	6	88a86286b9c3ea3b076d7464faec42d0392ee7f8
ToppCell	Parenchymal-10x5prime-Stromal-Mesofibroblastic-Mesothelia\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	GRIK2 EPGN PKHD1L1 ABCA8 C4A C4B	3.76e-05	197	140	6	2773d2eb5f232a7e49da116efffcb6bf5eb90810
ToppCell	Tracheal-NucSeq-Stromal-Schwann-Schwann_nonmyelinating\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GPR155 TRABD2B GRIK2 CSMD2 ABCA8 RORB	3.76e-05	197	140	6	5c88a97e8e23a5cd61885acbe1ef339ae6a1e35a
ToppCell	Biopsy_Other_PF-Mesenchymal-Mesothelial_cells\|Biopsy_Other_PF / Sample group, Lineage and Cell type	FLNC EPGN PKHD1L1 NSG1 C4A C4B	3.87e-05	198	140	6	86736f01e61bf4961f060b24ee1f1f48340737dd
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HECW1 CSMD2 CSMD3 ABCC8 CSPG4 PCDH15	3.98e-05	199	140	6	333056c2abe9724efeab542c0365fcfe4eff8f18
ToppCell	Biopsy_Control_(H.)-Mesenchymal-Mesothelial_cells\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	FLNC EPGN PKHD1L1 ABCA8 C4A C4B	3.98e-05	199	140	6	ca970114b5aef4518ce580897a62ac88688b2671
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6\|World / Primary Cells by Cluster	NBEA NSG2 CSRNP3 SRGAP1 NSG1 RORB	3.98e-05	199	140	6	1b1bccf4293f11048709d15a3c892c0edf3da3d2
ToppCell	Neuron\|World / Primary Cells by Cluster	ENC1 NBEA NSG2 CSRNP3 SRGAP1 NSG1	3.98e-05	199	140	6	1f8104fd92f04690b41d9d07ac08dc59d76bb97d
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HECW1 CSMD2 CSMD3 ABCC8 CSPG4 PCDH15	3.98e-05	199	140	6	e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698
ToppCell	Neuron-Postmitotic\|World / Primary Cells by Cluster	ENC1 NBEA NSG2 CSRNP3 SRGAP1 NSG1	3.98e-05	199	140	6	1973527f8a7d4c6490d75c0d0ea153688166a08b
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal\|World / Primary Cells by Cluster	NBEA NSG2 CSRNP3 SRGAP1 NSG1 RORB	3.98e-05	199	140	6	4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_\|World / Primary Cells by Cluster	ENC1 NBEA NSG2 CSRNP3 SRGAP1 NSG1	3.98e-05	199	140	6	058373b4ac3cec2108cb24265628ff0a50646e33
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	MYCBP2 NBEA NSG2 CSRNP3 NSG1 AGTPBP1	4.10e-05	200	140	6	bad32a95b759fad509401b07bc96a56687c2a592
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	MYH8 PKHD1L1 ACOD1 TAF9	4.35e-05	62	140	4	a20620a8869721ea62984c2022ee1b484b455824
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	MYH8 PKHD1L1 ACOD1 TAF9	4.35e-05	62	140	4	ee694c06bcd924b4ddf744178ba3a99e04eed51b
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col23a1_Adamts2\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MYH2 FGF16 PLET1 VWA3B	5.25e-05	65	140	4	f14b28214f80ed23501ab28ff254c206f70d77b2
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRABD2B GPR82 F5 TINAG ABCC8	5.28e-05	128	140	5	e100629f6038e32176ffcc81bd06bd175df46cef
ToppCell	facs-Pancreas-Exocrine-24m-Endothelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HECW1 PAQR5 GRIK2 PKHD1L1 FUT9	5.69e-05	130	140	5	8c81853c806e9a0d562e00dc5e00a8fc569a854c
ToppCell	facs-Pancreas-Exocrine-24m-Endothelial-endothelial_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HECW1 PAQR5 GRIK2 PKHD1L1 FUT9	5.69e-05	130	140	5	3041d20fe964d282d95c0312396f26bc93929056
ToppCell	facs-Pancreas-Exocrine-24m-Endothelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HECW1 PAQR5 GRIK2 PKHD1L1 FUT9	5.69e-05	130	140	5	3b6a8eaef593db73c2fad2260b9f1e15950ccb70
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_P2ry12\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TRABD2B FGF16 CLIC5 KYNU EPAS1	5.90e-05	131	140	5	80630812f8894b9358d36dc2dd03fea7ee870502
ToppCell	Mild/Remission-B_naive-1\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	WASHC4 ICE2 ICE1 PLEKHH2 RAB29	8.93e-05	143	140	5	bd3f5fbd4e9e4dc414682db5607494f3ce988deb
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	DCHS2 MIA3 FGF16 CCDC87 HYDIN	9.23e-05	144	140	5	08005be9e3367f78ef27e125d9cce5ca53f4bd2d
ToppCell	Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	MYH2 TRABD2B SV2B ABCC8 FUT9	1.23e-04	153	140	5	b37a1ecad389d2848b8ca4d287823e8048207420
ToppCell	facs-Marrow-KLS-18m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEBL ABCC9 ITGAX FAT1 C4A	1.27e-04	154	140	5	37765512dfae557b9f6eb30a29463b93682a4404
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW19-Neuronal\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	ENC1 NSG2 CSRNP3 NSG1	1.30e-04	82	140	4	dadc97c81e44858f60687145316102fc10ecc13e
ToppCell	lung-Type_I_Pneumocytes\|lung / shred on tissue and cell subclass	PLEKHG1 CLIC5 NSG1 RNF180	1.30e-04	82	140	4	6023212a51f8b3e05e6c3dcf4e8fbf53ba696fb2
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Trm_Tgd\|lymph-node_spleen / Manually curated celltypes from each tissue	SLC3A1 NUP205 DOCK5 PLEKHH2 EPAS1	1.30e-04	155	140	5	b0e456c4915076e1d38282e116a6eb3230ae80dc
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NEBL MUC19 EPGN FAT1 CLIC5	1.47e-04	159	140	5	8680b054622f573a82b1625fb93c2d5db81d1034
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ABCA8 ORMDL3 CLIC5 ZNF606 ZMAT1	1.47e-04	159	140	5	2233fee5dcdb6c7dee5b1bd8efbc07d86b339927
ToppCell	PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_macrophage_(16)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ITGAX ACOD1 BTK IL1A KYNU	1.51e-04	160	140	5	08696d93ff42a1beca23c70ab3e0d082cfff4aa7
ToppCell	facs-MAT-Fat-24m-Myeloid-myeloid_cell\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KDM6B F5 ACOD1 IL1A RNF180	1.56e-04	161	140	5	65888250b8c1da6a8f9b5376e086a3769a1cbbd8
Computational	Complement.	CR2 C4A C4B C4BPA	2.88e-05	23	85	4	MODULE_130
Disease	Colorectal Carcinoma	FLNC POLD1 POLE CSMD3 F5 ABCA8 ADCY8 HPS3 PARP1 FAT1 CSRNP3 ABCC8 ABCG2 CTNND2 AGTPBP1	1.01e-06	702	137	15	C0009402
Disease	pneumococcal bacteremia	LAMB4 OR6P1 DOCK7	1.57e-05	11	137	3	EFO_1001925
Disease	Colorectal Neoplasms	FLNC POLD1 POLE ABCA8 PARP1 FAT1 ABCC8 ABCG2	4.79e-05	277	137	8	C0009404
Disease	Drug habituation	GRIK2 CSMD3 CSRNP3 PCDH15 ZNF606	2.04e-04	115	137	5	C0013170
Disease	Drug abuse	GRIK2 CSMD3 CSRNP3 PCDH15 ZNF606	2.04e-04	115	137	5	C0013146
Disease	Prescription Drug Abuse	GRIK2 CSMD3 CSRNP3 PCDH15 ZNF606	2.04e-04	115	137	5	C4316881
Disease	Substance-Related Disorders	GRIK2 CSMD3 CSRNP3 PCDH15 ZNF606	2.04e-04	115	137	5	C0236969
Disease	Drug Use Disorders	GRIK2 CSMD3 CSRNP3 PCDH15 ZNF606	2.04e-04	115	137	5	C0013222
Disease	Drug Dependence	GRIK2 CSMD3 CSRNP3 PCDH15 ZNF606	2.04e-04	115	137	5	C1510472
Disease	Substance Dependence	GRIK2 CSMD3 CSRNP3 PCDH15 ZNF606	2.04e-04	115	137	5	C0038580
Disease	Substance Use Disorders	GRIK2 CSMD3 CSRNP3 PCDH15 ZNF606	2.04e-04	115	137	5	C0038586
Disease	Organic Mental Disorders, Substance-Induced	GRIK2 CSMD3 CSRNP3 PCDH15 ZNF606	2.04e-04	115	137	5	C0029231
Disease	Lipodystrophy	POLD1 PARP2	2.12e-04	5	137	2	C0023787
Disease	DiGeorge syndrome (is_implicated_in)	DVL1P1 DVL1	2.12e-04	5	137	2	DOID:11198 (is_implicated_in)
Disease	Substance abuse problem	GRIK2 CSMD3 CSRNP3 PCDH15 ZNF606	2.13e-04	116	137	5	C0740858
Disease	venous thromboembolism, fibrinogen measurement	DCHS2 F5 PTPRJ C4BPA	2.72e-04	67	137	4	EFO_0004286, EFO_0004623
Disease	renal cell carcinoma (is_implicated_in)	C4A C4B ABCG2 RNF139	3.04e-04	69	137	4	DOID:4450 (is_implicated_in)
Disease	Pituitary Gland Adenoma	NEBL PCDH15	3.17e-04	6	137	2	EFO_1000478
Disease	gout	ABCC9 FAT1 CLIC5 SV2B ABCC8 ABCG2	3.18e-04	196	137	6	EFO_0004274
Disease	thyroid peroxidase antibody measurement	NEBL CSMD2 DICER1 RORB	3.58e-04	72	137	4	EFO_0005666
Disease	Endometrial Carcinoma	PLXNA3 POLD1 POLE ABCC9	3.58e-04	72	137	4	C0476089
Disease	Cardiomyopathies	NEBL ABCC9 PARP1 TMEM70 IL1A	3.61e-04	130	137	5	C0878544
Disease	factor XI measurement, venous thromboembolism	F5 PTPRJ C4BPA	3.63e-04	30	137	3	EFO_0004286, EFO_0004694
Disease	Cerebral ventriculomegaly	SIN3A HYDIN	4.43e-04	7	137	2	C1531647
Disease	B-cell lymphoma (is_implicated_in)	BTK ABCG2	4.43e-04	7	137	2	DOID:707 (is_implicated_in)
Disease	Hydrocephalus Ex-Vacuo	SIN3A HYDIN	4.43e-04	7	137	2	C0270720
Disease	Communicating Hydrocephalus	SIN3A HYDIN	4.43e-04	7	137	2	C0009451
Disease	Fetal Cerebral Ventriculomegaly	SIN3A HYDIN	4.43e-04	7	137	2	C2936718
Disease	Post-Traumatic Hydrocephalus	SIN3A HYDIN	4.43e-04	7	137	2	C0477432
Disease	Obstructive Hydrocephalus	SIN3A HYDIN	4.43e-04	7	137	2	C0549423
Disease	factor VIII measurement, venous thromboembolism	F5 PTPRJ C4BPA	5.27e-04	34	137	3	EFO_0004286, EFO_0004630
Disease	dilated cardiomyopathy (implicated_via_orthology)	MYH2 FLNC MYH8 DICER1	5.35e-04	80	137	4	DOID:12930 (implicated_via_orthology)
Disease	Congenital Hydrocephalus	SIN3A HYDIN	5.88e-04	8	137	2	C0020256
Disease	Aqueductal Stenosis	SIN3A HYDIN	5.88e-04	8	137	2	C2936786
Disease	venous thromboembolism, factor VII measurement	F5 PTPRJ C4BPA	7.33e-04	38	137	3	EFO_0004286, EFO_0004619
Disease	Hydrocephalus	SIN3A HYDIN	7.54e-04	9	137	2	C0020255
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH2 MYH8	9.40e-04	10	137	2	DOID:0111269 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH2 MYH8	9.40e-04	10	137	2	DOID:0111602 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH2 MYH8	9.40e-04	10	137	2	DOID:0111596 (implicated_via_orthology)
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH2 MYH8	9.40e-04	10	137	2	DOID:0110454 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH2 MYH8	9.40e-04	10	137	2	DOID:0080719 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH2 MYH8	9.40e-04	10	137	2	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH2 MYH8	9.40e-04	10	137	2	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH2 MYH8	9.40e-04	10	137	2	DOID:0080326 (implicated_via_orthology)
Disease	venous thromboembolism, von Willebrand factor measurement	F5 PTPRJ C4BPA	9.85e-04	42	137	3	EFO_0004286, EFO_0004629
Disease	reticulocyte count	USP9X ENC1 TMEM235 ITGAX OR6P1 ADCY8 PLEK2 DOCK5 FAT1 PTPRJ TBK1 C4B C4BPA	1.19e-03	1045	137	13	EFO_0007986
Disease	reticulocyte measurement	USP9X ENC1 TMEM235 KDM6B ITGAX ADCY8 PLEK2 DOCK5 FAT1 PTPRJ TBK1 RORB C4BPA	1.28e-03	1053	137	13	EFO_0010700
Disease	distal myopathy (implicated_via_orthology)	MYH2 MYH8	1.37e-03	12	137	2	DOID:11720 (implicated_via_orthology)
Disease	myotonia congenita (implicated_via_orthology)	MYH2 MYH8	1.37e-03	12	137	2	DOID:2106 (implicated_via_orthology)
Disease	Autistic Disorder	GPR155 NBEA GRIK2 CSMD3 SND1 C4B	1.42e-03	261	137	6	C0004352
Disease	myopathy (implicated_via_orthology)	MYH2 FLNC MYH8	1.45e-03	48	137	3	DOID:423 (implicated_via_orthology)
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH2 MYH8	1.61e-03	13	137	2	DOID:397 (implicated_via_orthology)
Disease	cancer (implicated_via_orthology)	CAB39 POLE SIN3A BRCA2 EPAS1 TOP2B	1.62e-03	268	137	6	DOID:162 (implicated_via_orthology)
Disease	lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	DVL1P1 DVL1 BRCA2	1.83e-03	52	137	3	EFO_0000305, EFO_0000571, EFO_0000708, EFO_0001071, EFO_0001075, EFO_0001663, EFO_1000650, EFO_1001515, EFO_1001516, MONDO_0005575
Disease	free androgen index	MYH2 SIN3A ABCA8 DOCK5 PTPRG RORB EPAS1	1.87e-03	374	137	7	EFO_0007005
Disease	receptive language perception, parental genotype effect measurement	MUC19 PLEKHG1	1.88e-03	14	137	2	EFO_0005686, EFO_0005939
Disease	HMG CoA reductase inhibitor use measurement	TDRD15 MIA3 DHRS11 BRCA2 DOCK7	1.93e-03	189	137	5	EFO_0009932
Disease	macula measurement	DCHS2 STAT2 FAT1 RORB CTNND2	1.93e-03	189	137	5	EFO_0008375
Disease	peripheral arterial disease	NEBL CSMD3 F5	2.04e-03	54	137	3	EFO_0004265
Disease	lifestyle measurement, alcohol consumption measurement	GRIK2 CSMD2 ADCY8 NUP205	2.06e-03	115	137	4	EFO_0007878, EFO_0010724
Disease	sleep apnea measurement	HECW1 NEBL NBEA SND1	2.13e-03	116	137	4	EFO_0007817
Disease	phenylalanine measurement	WASHC4 PCDH15 KIF13A	2.15e-03	55	137	3	EFO_0005001
Disease	platelet storage pool deficiency (implicated_via_orthology)	HPS3 DOCK7	2.16e-03	15	137	2	DOID:2223 (implicated_via_orthology)
Disease	distal arthrogryposis (implicated_via_orthology)	MYH2 MYH8	2.16e-03	15	137	2	DOID:0050646 (implicated_via_orthology)
Disease	response to statin, LDL cholesterol change measurement	TDRD15 ABCG2	2.16e-03	15	137	2	EFO_0007804, GO_0036273
Disease	response to calcium channel blocker	MUC19 SND1 PCDH15	2.27e-03	56	137	3	EFO_0007767
Disease	testosterone measurement	STARD13 MYH2 DCHS2 MIA3 ICE2 SIN3A KDM6B CSMD3 ABCA8 DOCK5 PTPRG PTPRJ RORB EPAS1	2.48e-03	1275	137	14	EFO_0004908
Disease	colorectal cancer (is_implicated_in)	POLE DICER1 FAT1 PTPRJ	2.48e-03	121	137	4	DOID:9256 (is_implicated_in)
Disease	Endometrial Neoplasms	PLXNA3 POLD1 ABCC9	2.51e-03	58	137	3	C0014170
Disease	Brain Ischemia	F5 PARP1 IL1A	2.76e-03	60	137	3	C0007786
Disease	Cerebral Ischemia	F5 PARP1 IL1A	2.76e-03	60	137	3	C0917798
Disease	Multiple congenital anomalies	POLD1 KYNU	2.78e-03	17	137	2	C0000772
Disease	Hypogammaglobulinemia	CR2 BTK	2.78e-03	17	137	2	C0086438
Disease	systemic lupus erythematosus (is_implicated_in)	CR2 C4A C4B	3.03e-03	62	137	3	DOID:9074 (is_implicated_in)
Disease	total lipids in small VLDL	TDRD15 DOCK7 HSD17B4	3.78e-03	67	137	3	EFO_0022148
Disease	Deaf Mutism	POLD1 PCDH15	3.85e-03	20	137	2	C4082305
Disease	Deafness, Acquired	POLD1 PCDH15	3.85e-03	20	137	2	C0751068
Disease	Hearing Loss, Extreme	POLD1 PCDH15	3.85e-03	20	137	2	C0086395
Disease	Complete Hearing Loss	POLD1 PCDH15	3.85e-03	20	137	2	C0581883
Disease	Bilateral Deafness	POLD1 PCDH15	3.85e-03	20	137	2	C3665473
Disease	Prelingual Deafness	POLD1 PCDH15	3.85e-03	20	137	2	C0011052
Disease	lung non-small cell carcinoma (is_implicated_in)	POLE FAT1 IL1A EPAS1	4.08e-03	139	137	4	DOID:3908 (is_implicated_in)
Disease	Cardiomyopathies, Primary	PARP1 TMEM70 IL1A	4.10e-03	69	137	3	C0033141
Disease	Myocardial Diseases, Secondary	PARP1 TMEM70 IL1A	4.10e-03	69	137	3	C0036529
Disease	Lupus Erythematosus, Systemic	CR2 C4A C4B	4.44e-03	71	137	3	C0024141

Protein segments in the cluster

Peptide	Gene	Start	Entry
ISYHQLEAFYSIFTT	PTPRG	276	P23470
FSLHVLSKINIFYYS	TMEM62	471	Q0P6H9
VVRKDTTSHTYLQYS	ADCY8	231	P40145
HYKQSSSYSFFKEEI	C4BPA	436	P04003
TQYQDYSLSSAHKVS	EPAS1	806	Q99814
EHLTLTSYAVDSYEK	EPGN	96	Q6UW88
IYFSTLDYQDTTVHK	CATSPER3	351	Q86XQ3
QLYLHFYSDISVSAA	CSMD2	1881	Q7Z408
FKIHYESVTVNTYSC	CSMD3	996	Q7Z407
HLFVKSLNSASYLYE	CSPG4	921	Q6UVK1
DVHTAESISYQKLYN	CNTLN	371	Q9NXG0
YNYLDKNLTVSVHVS	C4B	856	P0C0L5
QSQYYLAEKHLFSTI	BTK	341	Q06187
ILKHSSLFLDSYTEY	ALS2	771	Q96Q42
YVNSSFYKETKAELH	ABCG2	336	Q9UNQ0
FSEYEKLLHSENYVT	CAB39	211	Q9Y376
NPEEHATYYFTTFSK	DOP1A	311	Q5JWR5
TTSIVYYHNIETSNF	ABCC9	116	O60706
TFAYITKDLQTSHHY	ANKS1A	1021	Q92625
TLSVDDYFKYLTNHE	CCDC87	591	Q9NVE4
NNTIFASLAVKYDYH	DICER1	1741	Q9UPY3
YYTITFTVNFPHKDD	AGTPBP1	826	Q9UPW5
LNTHEYDFVSVYTIK	CLIC5	51	Q9NZA1
QYSKHSQELYATATL	CTNND2	371	Q9UQB3
YVLVYSVTSLHSFQV	RHEBL1	81	Q8TAI7
RYSQDSFSKHYKSTV	RAB29	26	O14966
KYAVYTVVSSHEQFT	ITGAX	921	P20702
TVVSSHEQFTKYLNF	ITGAX	926	P20702
KYVKNTHATTHNAYD	PARP1	816	P09874
FFSYYDSHRQSVSKL	NUP205	1826	Q92621
EINYYFRSTAQSTKH	PCDHGB6	276	Q9Y5F9
SYEFKVISQYLQSTH	PARP2	376	Q9UGN5
TTFHDYYVALAVLNT	PAQR5	146	Q9NXK6
KIHATDQDVYDTLTY	FAT1	3566	Q14517
YTKYDAAHFLINTAS	ORMDL2	116	Q53FV1
DHLSLNQKSFYHVSY	IL1A	26	P01583
SNDTAASEYKYVVKH	PTPRJ	141	Q12913
VVLTSYYSFVSHLRK	GPR82	216	Q96P67
SVVNHTSLSNYAFLY	GPR155	306	Q7Z3F1
VLHANYSAYRVFTSS	HECW1	966	Q76N89
YLSFENSIHKDYITE	FUT9	241	Q9Y231
SRSHTTIAKYAQYQA	KDM6B	1271	O15054
RTKNVHFSCVTVYYF	CSRNP3	61	Q8WYN3
AYHVESKVYAVATST	CPSF1	1026	Q10570
KAERSYHIFYQITSN	MYH8	281	P13535
SVAAYTYRQHSVVFI	PLXNA3	416	P51805
ASSSYLQVETYFHVK	MUC19	911	Q7Z5P9
YSYNLCIASHSAKTE	PCDHGB1	746	Q9Y5G3
KAERSYHIFYQITSN	MYH2	281	Q9UKX2
RFYTVISHYSVAKQS	NSG2	131	Q9Y328
IDNHDYSYTVKYTAV	FLNC	921	Q14315
ASSVVYSATKDYKDH	PI4KA	686	P42356
LTAHSNYTQKTLKYF	LMNTD1	116	Q8N9Z9
DSSAREKFYTVINHY	NSG1	136	P42857
ISLKKNTHTYFYTSF	HM13	281	Q8TCT9
KQHTFTLAQYTYVAL	MOCOS	346	Q96EN8
YVEYITSSIHSKETF	POLE	1886	Q07864
IYFSDSLSTSIKYSH	PARP4	476	Q9UKK3
VQLTTEKHTYYLTAD	PLEKHH2	766	Q8IVE3
SLHSSAVAATYKYVN	NDUFS8	26	O00217
LFLSKELDYETTSHY	DCHS2	1461	Q6V1P9
VVHFYDDKVQSTYFL	KICS2	381	Q96MD2
LLQSKSELSHYTFYF	PAQR8	131	Q8TEZ7
TFKHESYYATVNELT	PCDH15	146	Q96QU1
YTFNHNKIISVLYTI	OR6P1	266	Q8NGX9
DQHVYKAVFTTSYPS	HENMT1	246	Q5T8I9
ASLVNYSFDTKDIHY	HYDIN	1381	Q4G0P3
ETQIVASDHTYYNSK	ICE1	1531	Q9Y2F5
VKKYSEFYTLHEVTS	ICE2	186	Q659A1
KTHSAYSHNDIVYVD	CR2	801	P20023
DSHYSHYISTFKTRQ	DOCK5	966	Q9H7D0
FSKEAYTAVVYHNRS	DOCK7	611	Q96N67
ITSHSDKITFHPYYT	MT-CYB	211	P00156
KTNKFIYAIHDETSY	BRCA2	586	P51587
VVQYAKEVVDFSSHY	FBXL4	51	Q9UKA2
FIYTTSNHIKYAVTT	COPA	541	P53621
YSYSEKELICHNQFS	HSD17B4	446	P51659
TTEVFHIASQYSKIY	ACOD1	46	A6NK06
DSSENIKKYYHISSS	LAMB4	1306	A4D0S4
RHTVNKITFSEQCYY	DVL1	481	O14640
YLFHKSSYADSVLTH	ENC1	21	O14682
ESTHKYYETVSDVLN	COG2	641	Q14746
RHTVNKITFSEQCYY	DVL1P1	456	P54792
HQVSDNKDSFYVSLY	GRIK2	136	Q13002
SVTHFYSATKYAVTA	DHRS11	161	Q6UWP2
LHYSFQTTEKLYFVL	SGK3	226	Q96BR1
EYKLRSYTLNAVSFH	POLD1	466	P28340
YNYLDKNLTVSVHVS	C4A	856	P0C0L4
FLTSFYTKYDQIHFV	ORMDL3	111	Q8N138
YTKYDQIHFVLNTVS	ORMDL3	116	Q8N138
YEIHSKTTAYSRLNE	RNF180	246	Q86T96
QYTVTFSHCKDYVVN	KIF13A	921	Q9H1H9
TSVLVNYYASLHIDF	RNF139	91	Q8WU17
YVTTILDDAKIYSSH	TAF9B	46	Q9HBM6
YVTTILDDAKIYSSH	TAF9	46	Q16594
STTSYKVVHSFDYAA	UTP15	276	Q8TED0
NEVNKVISSVSYYTH	USP9X	356	Q93008
ESNRSHTTIAKYAQY	UTY	971	O14607
HTTIAKYAQYQASSF	UTY	976	O14607
NLSSKESSFIHYYCV	SENP7	666	Q9BQF6
LSETFLHIYQYVSKE	STARD13	751	Q9Y3M8
TLEATNASVFKYYIH	SRGAP1	246	Q7Z6B7
EELHIISFTVKYTYQ	STAT2	426	P52630
SDYKEYHTDTTVKFV	TOP2B	976	Q02880
STIFYNTDLYEHKFI	SV2B	496	Q7L1I2
TVDYFTSKVHNKTVY	TDRD15	1426	B5MCY1
YFVRYKHSTAEETAT	MIA3	1026	Q5JRA6
YTQYEDESFTKHTVN	F5	396	P12259
YSNTYKTVKTQSCIH	HPS3	506	Q969F9
TYASTLYKHSDSERQ	FGF16	146	O43320
HTNTVTVTTYNTLYE	NBEA	801	Q8NFP9
FTKSISLLFHSINYY	GPR108	301	Q9NPR9
QTESKGSFSIQYTYH	SEMG1	56	P04279
TFVSSKKTQYEEHIY	SIN3A	596	Q96ST3
ALSKVHFTAERSSYY	SND1	626	Q7KZF4
TQYSELYHDFTTTQV	SLC3A1	341	Q07837
SLASIHADKYSYTID	SLC26A10	296	Q8NG04
SYSVVASEYDKQHSI	MYCBP2	3476	O75592
ITAKFTALYSLSQYH	ARHGAP5	911	Q13017
TTVVYNLTHEDSIKY	RNF217	316	Q8TC41
RVTFTNTYSYHLKFL	ABCA8	126	O94911
AAVTSVVYYHNIETS	ABCC8	116	Q09428
YTITLDIKASSHIYE	PLET1	41	Q6UQ28
DIKASSHIYESNAVY	PLET1	46	Q6UQ28
TKDDTHYYIQASSKA	PLEK2	326	Q9NYT0
ANTSTSFYKLVYTAI	ZNF678	16	Q5SXM1
IYISYSHLAFAETVQ	TMEM235	146	A6NFC5
YTHAANTVVYSSNKI	WDR82	71	Q6UXN9
SLQASYTTEDLIKHY	TRABD2B	241	A6NFA1
QTHTYEEIKAYQSKS	RORB	251	Q92753
HKASESQSFYVDVVY	PKHD1L1	816	Q86WI1
SFYLKEQTFYHVASD	TXNDC11	501	Q6PKC3
HYLDKTFYNLTTVAL	WASHC4	731	Q2M389
SSEYHENKKSYQTSV	ZNF510	376	Q9Y2H8
FVSKSEEFHIYTQYC	PLEKHG1	191	Q9ULL1
LSYIHVTVDTYSHFI	ERVK-19	666	Q9WJR5
KSFSYSSHYITHQTI	ZNF23	231	P17027
YQFVEHLTQAVESYK	VWA3B	106	Q502W6
IYRHVTSTNKESEKY	TINAG	391	Q9UJW2
YHEATTDTYKAITYN	TMEM70	171	Q9BUB7
AHKIYIHSYNTATIF	TBK1	321	Q9UHD2
ADSVYKYNIFRSTFH	ZNF181	151	Q2M3W8
FLTQHTSTYTAEKPY	ZNF606	386	Q8WXB4
YSVESEVYKHLSSEN	ZMAT1	511	Q5H9K5
YNSFHDVYKFTNLLT	KYNU	441	Q16719
IHSNTYNYKSTFSVE	NMD3	231	Q96D46
ISYRKDVQDTHTYSA	NEBL	161	O76041